A tool to help cancer patients overcome travel challenges for radiation therapy
Official title: Testing the Feasibility of a Transportation for Cancer Care Navigation Tool (TRACT) in Solid Tumors Patients Receiving Radiotherapy
Run by Emory University · NCT06541158 · Data updated 2026-11-12
This study is testing a new tool to help cancer patients with solid tumors get to their radiation therapy appointments more easily and see if it helps them stick to their treatment better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Emory University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 4 sites (Atlanta, Georgia and 3 other locations) |
| Status | Recruiting |
| Started | November 6, 2024 |
| Main results expected | May 15, 2028 |
| Study ends | May 15, 2028 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT06541158 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with solid tumors who are undergoing radiation therapy and experience travel barriers.
✕Probably not a fit
Patients receiving palliative care or those with major depression/anxiety disorders that interfere with participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the Transportation for Cancer Care Navigation Tool (TRACT) aimed at reducing travel barriers for patients with solid tumors undergoing radiation therapy. The study involves collaboration with a Community Advisory Board to refine the TRACT program, which includes screening for travel barriers, providing resources, and personalized transportation support. Patients will be randomized into two groups: one receiving the TRACT program and the other receiving standard care with additional informational resources. The trial will assess the feasibility and efficacy of the TRACT program on treatment adherence and patient-reported outcomes over a follow-up period of three months.
Why it matters
Potential benefit: If successful, this program could significantly improve treatment adherence and quality of life for cancer patients facing transportation challenges.
How similar studies have gone: While similar approaches to addressing travel barriers in cancer care have been explored, the TRACT program represents a novel intervention specifically tailored for patients undergoing radiation therapy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosed with solid tumors
* Undergoing RT (not excluded with chemotherapy)
* Competent to give consent
* English-speaking
* With travel barriers as screened by the reliable and validated 10-item Transportation Barriers Measure. In this study, item 2 ("how much trouble is it for you to get transportation to your doctor or treatment?") from the general barriers domain will be used to screen patients for travel barriers
Exclusion Criteria:
* Receive palliative care
* Are non-English-speaking (excluded due to pilot data without fund to support translation services)
* Are enrolled in lodging programs (e.g., the American Cancer Society \[ACS\] Hope Lodge®)
* Have major depression/anxiety disorders that interfere with their ability to participate (based on the electronic medical records report)
Where it's running
-
Emory University Hospital Midtown
Atlanta, Georgia, United States Recruiting -
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States Recruiting -
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States Recruiting -
Emory Proton Therapy Center
Atlanta, Georgia, United States Not yet recruiting
Study contacts
- Principal investigator: Jinbing Bai — Emory University Hospital/Winship Cancer Institute
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if virtual informed consent methods help people decide to join cancer research
This trial tests whether virtual human communicators and different consent messages can influence cancer patients’ understanding and willingness to participate in research.
-
AI-powered supportive care chatbot for young adult cancer survivors
A chatbot driven by artificial intelligence is tested to help young adult cancer survivors manage symptoms and care needs after treatment.
-
Telehealth pharmacist-led opioid education for cancer patients
This pilot tests a telehealth group education session led by a palliative care pharmacist to help adults with cancer use opioids more safely and effectively.
-
Mindfulness program to help with symptoms in chronic graft-versus-host disease
A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.
-
Non-invasive brain stimulation to help chemotherapy-induced nerve problems in cancer survivors
This trial tests whether a gentle brain stimulation method (tDCS) can help reduce numbness, tingling, and pain from CIPN in cancer survivors who are not currently in treatment.
-
Couples Coping Together Against Cancer: A Feasibility and Acceptability Look
This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.